Graphic Packaging Holding Company announced that its wholly-owned subsidiaries, Graphic Packaging International, Inc. and Graphic Packaging International Canada, ULC, have agreed to acquire the assets of Seydaco Packaging Corp. and its affiliates National Carton and Coating Co., and Groupe Ecco Boites Pliantes Ltée. Seydaco is a folding carton producer with a leading position in Canada focused on the foodservice, food, personal care, and household goods markets. Seydaco converts approximately 20,000 tons of paperboard annually and operates three converting plants located in Mississauga, Ontario, St.-Hyacinthe, Québec, and Xenia, Ohio. The business generated revenues of approximately $40 million and low double digit EBITDA margins on an LTM basis. Click Read More below for additional information.

According to the report, total Containerboard production in Q1 remained essentially flat (-0.4%) compared to Q1 2024. The operating rate for Unbleached Kraft Liner decreased compared to Q1 2024, while rates for all the other grades increased. The rates for all 4 grades were above 90% for the first time in over a year. Production for export increased in Q1 after 2 consecutive quarterly declines in the 2nd half of 2024, but it was still 7.7% lower than Q1 2024. Domestic new supply for Q1 increased 1.0% from the same quarter last year, but declined 3.8% from Q4 2024, which had been the strongest quarter since 2022. Inventories at mills at the end of Q1 declined 4.2% from their December 2024 levels. They were nevertheless 6.8% higher than the average mill inventories for the last 15 months.

Aptar announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site. This investment will help Aptar meet the growing prescription and consumer healthcare customer demand for proprietary drug delivery systems in North America. The North America Capacity Extension will benefit local customers. Manufacturing began at Aptar Congers in 2002 with a cleanroom and the production of Aptar Pharma’s VP3 pumps, and today the site manufactures a wide range of proprietary drug delivery products for nasal and injectable delivery routes. To support increasing patient demand for systemic nasal delivery, Aptar Pharma is significantly expanding the manufacturing capacity of its proprietary Unidose (UDS) Nasal Spray Systems via the addition of molds and assembly lines in cleanroom manufacturing settings, with the additional capacity planned to come online in Q4 2024.